Eric Rose

Eric Rose

Chief Tech/Sci/R&D Officer presso MESOBLAST LIMITED

Patrimonio netto: 11 431 $ in data 31/03/2024

73 anni
Health Technology
Finance
Consumer Services

Profilo

Eric A.
Rose
is the founder of VTVX Holdings I LLC.
He currently holds the position of Chairman at LongView Ventures LLC.
Additionally, he is the Executive Director & Chief Medical Officer at Mesoblast Ltd., Director at Orchestra BioMed, Inc., Non-Executive Director at Orchestra Biomed Holdings, Inc., and Advisor at KBL Healthcare Ventures.
He is also a member of the Strategic Advisory Board at Broadview Ventures, Inc. In the past, he served as Chairman at SIGA Technologies, Inc., Chairman-Surgery Department at NewYork-Presbyterian Hospital, Chairman-Health Evidence & Policy Department at Icahn School of Medicine at Mount Sinai, Chairman-Surgery Department at Columbia University College of Physicians & Surgeons, and Independent Director at ABIOMED, Inc. He has also held positions as a Director at Nexell Therapeutics, Inc., Keryx Biopharmaceuticals, Inc., Nephros, Inc., CircuLite, Inc., PharmaCore, Inc., and the National Preparedness & Response Science Board.
He was the President of the International Society for Heart & Lung Transplantation and served as Executive Vice President-Life Sciences at MacAndrews & Forbes LLC and MacAndrews & Forbes Holdings, Inc. Dr. Rose received his undergraduate and doctorate degrees from Columbia University College of Physicians & Surgeons.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
22/03/2024 2 169 ( 0.01% ) 11 431 $ 31/03/2024
10/01/2024 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Eric Rose

SocietàPosizioneInizio
MESOBLAST LIMITED Chief Tech/Sci/R&D Officer 01/02/2022
ORCHESTRA BIOMED HOLDINGS, INC. Director/Board Member 26/01/2023
LongView Ventures LLC Chairman -
Consultant / Advisor -
Director/Board Member 01/12/2018
Corporate Officer/Principal 01/01/2007
Consultant / Advisor -
Tutte le posizioni attive di Eric Rose

Precedenti posizioni note di Eric Rose

SocietàPosizioneFine
ABIOMED, INC. Director/Board Member 22/12/2022
SIGA TECHNOLOGIES, INC. Chief Executive Officer 13/10/2016
░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Eric Rose

Formazione di Eric Rose

Columbia University College of Physicians & Surgeons Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Eric Rose

Relazioni

100 +

Relazioni di 1° grado

21

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
SIGA TECHNOLOGIES, INC.

Health Technology

NEPHROS, INC.

Health Technology

MESOBLAST LIMITED

Health Technology

ORCHESTRA BIOMED HOLDINGS, INC.

Health Technology

Aziende private15

Health Technology

Health Technology

Health Technology

Commercial Services

Distribution Services

International Society for Heart & Lung Transplantation

Health Services

Finance

Finance

Health Technology

Finance

Finance

National Preparedness & Response Science Board

Health Technology

LongView Ventures LLC

Vedi le connessioni aziendali